ACHIEVE LIFE SCIENCES, INC. (ACHV) is a Health Care company in the In Vitro & In Vivo Diagnostic Substances industry (SEC CIK 0000949858). Net income in FY2025 was $-0.05B (diluted EPS $-1.25).
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 |
|---|
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-218175 | May 7, 2026 | May 12, 2026 | May 12, 2026 11:20 UTC | EDGAR |
| 10-Q |
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| FY21Dec '21 |
|---|
| Revenue | — | — | — | — | — |
|---|---|---|---|---|---|
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | $-0.05B | $-0.04B | $-0.03B | $-0.04B | $-0.03B |
| EPS (Diluted) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.04B | $0.04B | $0.02B | $0.03B | $0.05B |
| Total Liabilities | $0.02B | $0.02B | $0.02B | $0.02B | $0.02B |
| Stockholders' Equity | $0.02B | $0.02B | $-0.00B | $0.01B | $0.03B |
| Cash & Equivalents | $0.02B | $0.01B | $0.02B | $0.02B | $0.04B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-0.05B | $-0.03B | $-0.02B | $-0.04B | $-0.03B |
| Capital Expenditures | $0.00B | — | $0.00B | — | — |
| Free Cash Flow | $-0.05B | — | $-0.02B | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | — | — | — | — | — |
| Net Margin | — | — | — | — | — |
| Return on Equity | -254.0% | -190.6% | 2059.0% | -510.1% | -118.2% |
| Return on Assets | -130.8% | -103.1% | -153.9% | -141.3% | -69.8% |
| Debt / Equity | 0.94× | 0.85× | — | 2.61× | 0.69× |
| 0001193125-26-218177 |
| Mar 31, 2026 |
| May 12, 2026 |
| May 12, 2026 11:21 UTC |
| EDGAR |
| 10-K/Aamend | 0001193125-26-197402 | Dec 31, 2025 | Apr 30, 2026 | Apr 30, 2026 20:20 UTC | EDGAR |
| 8-K | 0001193125-26-159189 | Apr 15, 2026 | Apr 16, 2026 | Apr 16, 2026 20:47 UTC | EDGAR |
| 8-K | 0001193125-26-120687 | Mar 24, 2026 | Mar 24, 2026 | Mar 24, 2026 11:05 UTC | EDGAR |
| 10-K | 0001193125-26-120690 | Dec 31, 2025 | Mar 24, 2026 | Mar 24, 2026 11:10 UTC | EDGAR |
| 8-K | 0001193125-25-268056 | Nov 6, 2025 | Nov 6, 2025 | Nov 6, 2025 12:10 UTC | EDGAR |
| 10-Q | 0001193125-25-268074 | Sep 30, 2025 | Nov 6, 2025 | Nov 6, 2025 12:15 UTC | EDGAR |
Direct links to SEC EDGAR. ACHV has additional filings available on the SEC site.
